Literature DB >> 25584943

Biomechanical simulation and analysis of scoliosis correction using a fusionless intravertebral epiphyseal device.

Julien Clin1, Carl-Éric Aubin, Stefan Parent.   

Abstract

STUDY
DESIGN: Computer simulations to analyze the biomechanics of a novel compression-based fusionless device (hemistaple) that does not cross the disc for the treatment of adolescent idiopathic scoliosis.
OBJECTIVE: To biomechanically model, simulate, and analyze the hemistaple action using a human finite element model (FEM). SUMMARY OF BACKGROUND DATA: A new fusionless growth sparing instrumentation device (hemistaple), which locally compresses the growth plate without spanning the disc, was previously developed and successively tested on different animal models.
METHODS: Patient-specific FEMs of the spine, rib cage, and pelvis were built using radiographs of 10 scoliotic adolescents (11.7 ± 0.9 yr; Cobb thoracic: 35° ± 7°, lumbar: 24° ± 6°). A validated algorithm allowed simulating the growth (0.8-1.1 mm/yr/vertebra) and growth modulation process (Hueter-Volkmann principle) during a period of 2 years. Four instrumentation configurations on the convex curves were individually simulated (Config 1: 5 thoracic vertebrae with hemistaples on superior endplates; Config 2: same as Config 1 with hemistaples on both endplates; Config 3: same as Config 1 + 4 lumbar vertebrae; Config 4: same as Config 2 + 4 lumbar vertebrae).
RESULTS: Without hemistaples, on average the thoracic and lumbar Cobb angles, respectively, progressed from 35° to 56° and 24° to 30°, whereas the vertebral wedging at curve apices progressed from 5° to 12°. With the hemistaple Config 1, the Cobb angles progressed but were limited to 42° and 26°, whereas the wedging ended at 8°. With Config 3, Cobb and wedging were kept nearly constant (38°, 21°, 7°). With hemistaples on both endplates (Config 2, Config 4), the Cobb and wedging were all reduced (thoracic Cobb for Config 2 and 4: 24° and 15°; lumbar Cobb: 21° and 11°; wedging: 2° and 1°).
CONCLUSION: This study suggests that the hemistaple has the biomechanical potential to control the scoliosis progression and highlights the importance of the instrumentation configuration to correct the spinal deformities. It biomechanically supports the new fusionless device concept as an alternative for the early treatment of idiopathic scoliosis. LEVEL OF EVIDENCE: 5.

Entities:  

Mesh:

Year:  2015        PMID: 25584943     DOI: 10.1097/BRS.0000000000000777

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  Prediction outcomes for anterior vertebral body growth modulation surgery from discriminant spatiotemporal manifolds.

Authors:  William Mandel; Olivier Turcot; Dejan Knez; Stefan Parent; Samuel Kadoury
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-07-29       Impact factor: 2.924

2.  Porcine spine finite element model: a complementary tool to experimental scoliosis fusionless instrumentation.

Authors:  Bahe Hachem; Carl-Eric Aubin; Stefan Parent
Journal:  Eur Spine J       Date:  2017-01-09       Impact factor: 3.134

3.  Population-based design and 3D finite element analysis of transforaminal thoracic interbody fusion cages.

Authors:  Yifeng Yu; Wenjing Li; Lingjia Yu; Hao Qu; Tong Niu; Yu Zhao
Journal:  J Orthop Translat       Date:  2020-01-09       Impact factor: 5.191

Review 4.  2016 SOSORT guidelines: orthopaedic and rehabilitation treatment of idiopathic scoliosis during growth.

Authors:  Stefano Negrini; Sabrina Donzelli; Angelo Gabriele Aulisa; Dariusz Czaprowski; Sanja Schreiber; Jean Claude de Mauroy; Helmut Diers; Theodoros B Grivas; Patrick Knott; Tomasz Kotwicki; Andrea Lebel; Cindy Marti; Toru Maruyama; Joe O'Brien; Nigel Price; Eric Parent; Manuel Rigo; Michele Romano; Luke Stikeleather; James Wynne; Fabio Zaina
Journal:  Scoliosis Spinal Disord       Date:  2018-01-10

5.  In vitro analysis of the segmental flexibility of the thoracic spine.

Authors:  Hans-Joachim Wilke; Andrea Herkommer; Karin Werner; Christian Liebsch
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.